中/EN
中文繁體
English
Investor Relations
IR Home
Corporate Overview
Financial Highlights
Financial Reports
ESG Reports
Regulatory Filings
Press Releases
Company Presentations
Stock Quotes & Charts
Analyst Coverage
FAQs
IR Contact
Corporate
Investor Relations
IR Home
Corporate Overview
Financial Highlights
Financial Reports
ESG Reports
Regulatory Filings
Press Releases
Company
Presentations
Stock Quotes &
Charts
Analyst Coverage
FAQs
IR Contact
Press Releases
2007
Please select
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
NOV
04
TUL Granted an EU Certificate of Suitability; Products Acquired International Standard Accreditation
SEP
23
The United Laboratories International Holdings Limited Announces 2007 Interim Results
JUN
15
TUL Recorded a Solid Trading Debut - Share Price Gained 31.27% to Close at HK$3.61
JUN
13
TUL Announces Results of Share Offer - Public Offer Received 26.87 Times Over-subscription, Final Offer Price Set at Top-end HK$2.75 Per Share
JUN
03
TUL Announces Initial Public Offering - Raise HK$675 Million to HK$825 Million for Business Expansion to Capture the Future Growth of Pharmaceutical Industry in China